Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Islets of Langerhans Transplantation | 2 | 2021 | 179 | 1.230 |
Why?
|
| Kidney Transplantation | 4 | 2021 | 326 | 0.910 |
Why?
|
| Transplantation, Heterologous | 10 | 2021 | 241 | 0.810 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 38 | 0.660 |
Why?
|
| Precision Medicine | 1 | 2020 | 134 | 0.580 |
Why?
|
| Graft Survival | 5 | 2021 | 300 | 0.520 |
Why?
|
| Gene Silencing | 1 | 2020 | 436 | 0.520 |
Why?
|
| CD47 Antigen | 3 | 2021 | 6 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 630 | 0.470 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 60 | 0.420 |
Why?
|
| Nanoparticles | 1 | 2020 | 552 | 0.410 |
Why?
|
| Graft Rejection | 6 | 2021 | 304 | 0.410 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 240 | 0.370 |
Why?
|
| General Surgery | 1 | 2014 | 210 | 0.360 |
Why?
|
| Swine | 9 | 2021 | 397 | 0.320 |
Why?
|
| Heterografts | 2 | 2020 | 67 | 0.310 |
Why?
|
| Clinical Competence | 1 | 2014 | 731 | 0.300 |
Why?
|
| Transplantation Tolerance | 2 | 2020 | 69 | 0.300 |
Why?
|
| Bone Marrow Transplantation | 2 | 2020 | 140 | 0.300 |
Why?
|
| Podocytes | 2 | 2019 | 12 | 0.290 |
Why?
|
| Thymus Gland | 2 | 2020 | 240 | 0.280 |
Why?
|
| Lung Transplantation | 2 | 2019 | 74 | 0.280 |
Why?
|
| Papio | 7 | 2021 | 22 | 0.270 |
Why?
|
| Animals, Genetically Modified | 7 | 2021 | 312 | 0.250 |
Why?
|
| Internship and Residency | 1 | 2014 | 802 | 0.250 |
Why?
|
| Galactosyltransferases | 2 | 2020 | 15 | 0.200 |
Why?
|
| Animals | 12 | 2021 | 21459 | 0.200 |
Why?
|
| Proteinuria | 2 | 2021 | 41 | 0.180 |
Why?
|
| Papio hamadryas | 1 | 2020 | 1 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 248 | 0.150 |
Why?
|
| HMGB1 Protein | 1 | 2019 | 26 | 0.150 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 57 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2020 | 286 | 0.140 |
Why?
|
| Free Tissue Flaps | 1 | 2018 | 3 | 0.140 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 23 | 0.140 |
Why?
|
| Mammary Arteries | 1 | 2018 | 11 | 0.140 |
Why?
|
| B7-1 Antigen | 1 | 2018 | 74 | 0.140 |
Why?
|
| Mammaplasty | 1 | 2018 | 47 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 199 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 414 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 565 | 0.120 |
Why?
|
| Primates | 3 | 2020 | 52 | 0.110 |
Why?
|
| Immune Tolerance | 3 | 2020 | 186 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 1041 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1633 | 0.090 |
Why?
|
| Humans | 9 | 2021 | 65645 | 0.080 |
Why?
|
| Lymphocyte Depletion | 2 | 2020 | 96 | 0.080 |
Why?
|
| Swine, Miniature | 2 | 2019 | 9 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2020 | 194 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1233 | 0.070 |
Why?
|
| Models, Animal | 2 | 2020 | 242 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2014 | 2113 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2014 | 3329 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2020 | 472 | 0.060 |
Why?
|
| Kidney | 2 | 2020 | 458 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2189 | 0.050 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2020 | 35 | 0.040 |
Why?
|
| Thymectomy | 1 | 2020 | 35 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2020 | 41 | 0.040 |
Why?
|
| Chimerism | 1 | 2019 | 12 | 0.040 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 29 | 0.040 |
Why?
|
| alpha-Galactosidase | 1 | 2019 | 8 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 215 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 101 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 48 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 97 | 0.040 |
Why?
|
| Catheters | 1 | 2020 | 83 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2019 | 63 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 209 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2019 | 176 | 0.040 |
Why?
|
| Nephrosis, Lipoid | 1 | 2018 | 7 | 0.030 |
Why?
|
| Nephrosis | 1 | 2018 | 4 | 0.030 |
Why?
|
| Urinalysis | 1 | 2018 | 37 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 72 | 0.030 |
Why?
|
| Abatacept | 1 | 2018 | 67 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 257 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2018 | 159 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 118 | 0.030 |
Why?
|
| Adult | 1 | 2014 | 17511 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2018 | 178 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 874 | 0.030 |
Why?
|
| Time Factors | 1 | 2020 | 3777 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5820 | 0.020 |
Why?
|
| Middle Aged | 1 | 2018 | 18439 | 0.010 |
Why?
|
| Female | 1 | 2018 | 34309 | 0.010 |
Why?
|